Piscataway, NJ, January 11, 2023–Camber Pharmaceuticals is pleased to announce the addition of Diclofenac Potassium for Oral Solution to its current portfolio.
Diclofenac Potassium for Oral Solution is a non-steroidal anti-inflammatory drug (NSAID) indicated for the acute treatment of migraine attacks with or without aura, in adults 18 years of age or older.
Diclofenac Potassium for Oral Solution is available in 50 mg strength and supplied as a box of 9 individual packets.
To find out more about Diclofenac Potassium for Oral Solution please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected]
